SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Consultation — Jack London
| Patient | Jack London |
|---|
| Date of birth | 1987-01-12 |
|---|
| Identifiers | MRN HR-ET010-SYN; SSN (made up) 000-10-4482 |
|---|
| Document date | 2026-08-18 |
|---|
| Author | Teodor Mbatha-Rasmussen, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Reduced kidney function (creatinine 1.98 mg/dL, eGFR 43) with albumin in the urine (240 mg/g) and untreated high blood pressure (158/98) in a 39-year-old writer with severe alcohol use disorder, who has taken naproxen most days for two years. Please confirm the stage and cause, and advise on blood pressure, an SGLT2 inhibitor, medicine for his alcohol use disorder at this kidney function, and pain relief. [S]
Urgency: Within two weeks. [S]
Questions for the consultant:
- Is this chronic kidney disease, what is its KDIGO stage, and what is the most likely cause: hypertension, naproxen, alcohol, stones, gout, or a disease that needs a biopsy?
- What blood pressure target and losartan dose do you advise, and how should potassium and creatinine be followed?
- Should he start an SGLT2 inhibitor now, given his heavy drinking?
- Which medicine for alcohol use disorder is safe at his kidney function (naltrexone or acamprosate), and is the outpatient withdrawal plan safe for his kidneys and liver?
- Which pain medicines are safe for him, and what should we avoid?
History of Present Illness
Mr. London, 39, a novelist who writes every morning on his ranch, is seen at the request of Dr. Whitcombe-Ibe two weeks after reduced kidney function, albumin in the urine and high blood pressure were found, together with severe alcohol use disorder. He stopped drinking the day after the intake visit and completed a five-day chlordiazepoxide taper without complications; he has had no alcohol for twelve days. He stopped naproxen and takes acetaminophen. He has taken losartan 50 mg for two weeks without dizziness. He has never passed a stone or had gout, blood in the urine or a rash. He remembers being told years ago that his kidneys were damaged, at an operation for his appendix. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- He was born on January 12, 1876, in San Francisco, and his birth certificate named him John Griffith Chaney. His mother, Flora Wellman, had lived with William Chaney, an astrologer, who left before the birth; she married John London, who adopted and raised the boy. [D]
- He grew up poor and worked from boyhood: an oyster pirate at 15, on the fish patrol at 16, an able-bodied seaman at 17, and a tramp crossing America at 18, when he spent a month in jail. [D]
- He went to the Klondike gold fields in 1897, at 21, and came home with very little after suffering scurvy. [D]
- He became internationally famous with The Call of the Wild (1903) and The Sea Wolf (1904), completed more than 50 books between 1900 and 1916, was at his peak the highest paid writer in the United States, and pushed to write 1,000 words a day wherever he was. [D]
- From 1905 he bought land at Glen Ellen in the Sonoma Valley and built up his Beauty Ranch; Wolf House, his nearly finished stone and redwood home, burned on August 22, 1913, a crushing financial loss. The loss left him depressed, but he forced himself back to work. [D]
- On the voyage of his yacht Snark through the South Pacific (1907 to 1909), in the Solomon Islands he had sores that a physician in Fiji called yaws and a missionary said were not; his hands swelled and peeled and his toenails thickened, a malady the Australian specialists could not name; he spent five weeks in hospital in Australia, gave up the voyage, and blamed tropical light. He also had a 'silvery skin' that doctors called by old names for leprosy, which cleared without treatment in California. [D]
- Physicians writing since have interpreted his illnesses differently: the 'silvery skin' has been read as psoriasis; one review proposed that mercury used to treat yaws damaged his kidneys and caused a dermatitis of the hands, feet and face; others suggested lupus, gout, and the effects of tobacco, alcohol and diet on his blood pressure and kidneys. None is established. [R]
- In John Barleycorn (1913) he wrote of his drinking from the first time he got drunk, at five years old. He held that he was no born alcoholic and had acquired the taste, and described how at the ranch, after writing his thousand words between nine and eleven each morning, he began to take a cocktail before midday dinner and then alone, 'not for the sake of the taste, but for the effect of the drink.' [D]
- In July 1913 he had his appendix removed, and serious kidney damage was found; his physician diagnosed a significant kidney problem at that time. [D]
- In 1914 he went to Vera Cruz as a war correspondent in the Mexican Revolution and was ill with dysentery and rheumatism. [D]
- He spent February 24 to July 22, 1915, in Hawaii and sailed there again on December 16, 1915; his health was described that year as declining. [D]
- He married Bess Maddern in 1900; their daughters Joan and Bess were born in 1901 and 1902, and the marriage ended in divorce in 1905. He married Charmian Kittredge in November 1905. [D]
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Naproxen 500 mg oral tablet twice daily, bought over the counter at full strength and taken most days for about two years for knee and back pain; stopped at intake | One tablet by mouth twice a day, self-directed | Oral route | 2024-08-01 to 2026-08-04 | stopped | S |
| Losartan 50 mg oral tablet once daily | One tablet by mouth every morning | Oral route | 2026-08-04 to 2026-09-15 | completed | S |
| Chlordiazepoxide 25 mg oral capsule, fixed five-day taper for alcohol withdrawal (four capsules on day 1, three on day 2, two on day 3, one on days 4 and 5), dispensed for five days only, with a daily telephone check | Up to one capsule four times a day on day 1, tapering to one a day by day 4; stop after day 5; no alcohol or driving | Oral route | 2026-08-04 to 2026-08-08 | completed | S |
| Thiamine 100 mg oral tablet once daily | One tablet by mouth daily | Oral route | 2026-08-04 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for pain, no more than 2,000 mg in a day, in place of naproxen | One to two tablets by mouth every six hours as needed; no more than four tablets a day | Oral route | 2026-08-04 | active | S |
| Naltrexone 50 mg oral tablet once daily, with a wallet card warning that it blocks opioid pain medicines | One tablet by mouth every morning | Oral route | 2026-08-18 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultation | resolved | confirmed |
R94.4 | S — Synthetic presenting problem anchored to the documented kidney damage found in 1913; superseded when the consultation staged chronic kidney disease. |
| Chronic kidney disease, stage G3b A2 (eGFR 42 to 43, urine albumin 240 mg/g), most likely from hypertension with a contribution from two years of daily naproxen; kidneys of normal size, without stones or obstruction; urine sediment bland; synthetic modern diagnosis linked to his documented kidney disease | active | confirmed |
N18.32 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented kidney damage and death from uraemia; the cause in the modern episode is synthetic and is not a claim about his real kidneys. |
| Hypertensive chronic kidney disease, untreated until intake | active | confirmed |
I12.9 | S — Synthetic modern diagnosis made at the consultation. |
| Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mL | active | confirmed |
F10.20 | S — Synthetic modern diagnosis anchored to his own published account of heavy drinking; the criteria, scores and amounts are synthetic and are not a claim about his real drinking. |
| Alcohol-associated fatty liver without advanced fibrosis (liver stiffness 7.2 kPa; steatosis on ultrasound); FIB-4 2.28 at intake | active | confirmed |
K70.0 | S — Synthetic finding of the ultrasound and elastography at the consultation; not a claim about his real liver. |
| Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its place | resolved | confirmed |
Z79.1 | S — Synthetic medication history; the joint pain is anchored to the documented rheumatism of 1914, which is not given a diagnosis. |
| Cigarette smoking, about ten a day; not ready to stop while he stops drinking | active | confirmed |
F17.210 | S — Synthetic tobacco use; a physician-author's suggestion of heavy tobacco use is recorded only as a retrospective claim. |
Physical Exam
Vital signs recorded on 2026-08-18; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Well; blood pressure 146/92, pulse 84; weight 83.6 kg |
| Cardiovascular | Regular rhythm; no murmur or bruit; trace ankle edema |
| Skin | No rash, purpura or tophi |
| Neurological | No tremor |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-08-18 | Potassium [Moles/volume] in Serum or Plasma | 4.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-08-18 | Creatinine [Mass/volume] in Serum or Plasma | 2.04 | mg/dL | 0.74-1.35 mg/dL | High | S |
| 2026-08-18 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 42 | mL/min/{1.73_m2} | 45 to 59 is G3a; 30 to 44 is G3b | Low | S |
| 2026-08-18 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 49 | U/L | 10-40 U/L | High | S |
| 2026-08-18 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 36 | U/L | 9-46 U/L | Normal | S |
| 2026-08-18 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 141 | U/L | 8-61 U/L | High | S |
Assessment
- Chronic kidney disease G3b A2 (N18.32). Chronic kidney disease, stage G3b A2 by KDIGO 2024: an eGFR of 42 to 43 with albumin 240 mg/g, and a creatinine already 1.7 mg/dL fourteen months ago, so it has lasted more than three months; high risk on the KDIGO heat map. Normal-sized echogenic kidneys, a bland sediment without blood, moderate rather than heavy albuminuria and long-standing untreated hypertension point to hypertensive kidney disease, with two years of daily naproxen adding harm. There are no stones or obstruction, and no gout attacks; the uric acid of 8.4 mg/dL does not need treatment without gout. Alcohol raises blood pressure but is not itself a usual cause of this picture. Nothing suggests a glomerulonephritis or another disease that needs a biopsy now; hepatitis B, hepatitis C and HIV serology are drawn today, and a biopsy would be reconsidered for blood in the urine, rising albumin or a fall in eGFR without explanation. A cystatin C estimate is not needed now, since no decision hinges on it. 25-hydroxyvitamin D was not drawn and should be. [S]
- Blood pressure (I12.9). Aim for a systolic below 120 by standardized office measurement if he tolerates it, as KDIGO 2021 advises, and at least below 130/80 as the 2025 AHA/ACC guideline does. Losartan should go to the maximum tolerated dose, 100 mg, because it lowers albuminuria as well as pressure; potassium 4.9 and a 3 percent rise in creatinine are acceptable. Check potassium and creatinine two to four weeks after each change; accept a creatinine rise of up to 30 percent. Less than 2 g of sodium a day; amlodipine would be the next step. [S]
- SGLT2 inhibitor (N18.32). He meets the KDIGO 2024 recommendation for an SGLT2 inhibitor (eGFR 20 or more with albumin 200 mg/g or more), which slows kidney decline whether or not there is diabetes. But heavy drinking, missed meals and vomiting raise the risk of ketoacidosis on these drugs, even without diabetes. I advise waiting until he has been abstinent for some weeks and is eating regularly, then dapagliflozin 10 mg daily with written sick-day rules, and potassium and creatinine two to four weeks after starting, expecting an early dip in eGFR. [S]
- Medicine for alcohol use disorder (F10.20). Naltrexone is the better choice. It is cleared mainly by the liver, needs no dose change at his kidney function, and his liver tests are falling and under three times normal; he takes no opioids. Acamprosate is cleared by the kidneys: at a creatinine clearance of 30 to 50 mL/min the dose must be cut to 333 mg three times a day and below 30 it should not be used, and with his clearance near 58 and likely to change, and a three-times-a-day schedule he says he would not keep, it is a second choice. The outpatient chlordiazepoxide taper was reasonable for his kidneys, since it is cleared by the liver, and safe for a liver without cirrhosis; in a man with cirrhosis or worse liver function a shorter-acting benzodiazepine would be preferred. Disulfiram is not advised. [S]
- Pain relief (Z79.1). No naproxen, ibuprofen, high-dose aspirin or other oral anti-inflammatory medicines, which cut kidney blood flow and caused part of this damage. Acetaminophen is the first choice, kept to 2,000 mg a day after heavy drinking. A short course of a topical anti-inflammatory gel on a small area is acceptable, because blood levels are low. No opioids or tramadol: naltrexone blocks opioids, morphine's active products build up when the kidneys are weak, and opioids add risk in early recovery. Any new medicine should be checked for kidney dosing, and iodinated contrast used only with precautions. [S]
Data reviewed: Dr. Whitcombe-Ibe's intake note and results: creatinine 1.98 mg/dL, eGFR 43, urine albumin-to-creatinine ratio 240 mg/g, uric acid 8.4 mg/dL, PTH 74 pg/mL, hemoglobin 13.6 g/dL, AST 68, ALT 41, GGT 186 U/L, FIB-4 2.28, PEth 410 ng/mL, HbA1c 5.4%. Urinalysis: 2+ protein, no blood, no casts or crystals. Insurance examination report: creatinine 1.7 mg/dL about fourteen months ago. Today: potassium 4.9 mmol/L, creatinine 2.04 mg/dL (eGFR 42), AST 49, ALT 36, GGT 141 U/L. Ultrasound this morning: kidneys 10.8 and 11.0 cm, echogenic, no stones, hydronephrosis or cysts; fatty liver; normal spleen. Elastography: liver stiffness 7.2 kPa, controlled attenuation parameter 312 dB/m. Kidney failure risk equation: five-year risk about 5 percent, two-year about 1.5 percent. Estimated creatinine clearance (Cockcroft-Gault) about 58 mL/min. [S]
Plan of Treatment
- Chronic kidney disease G3b A2, most likely hypertensive with naproxen contributing; no biopsy now; hepatitis B, hepatitis C and HIV serology today; 25-hydroxyvitamin D with the next blood test. [S]
- Losartan raised to 100 mg at about six weeks if potassium allows, with potassium and creatinine two to four weeks after each change; systolic target below 120 if tolerated; sodium below 2 g a day; amlodipine next if needed. [S]
- Dapagliflozin 10 mg daily once he has been abstinent for some weeks and is eating regularly, with written sick-day rules and potassium and creatinine two to four weeks later. [S]
- Naltrexone 50 mg daily, with a wallet card and liver tests at four to six weeks; acamprosate only as a second choice at a reduced dose, and not below a creatinine clearance of 30. [S]
- No oral NSAIDs, no opioids or tramadol; acetaminophen up to 2,000 mg a day; topical gels for short courses only. [S]
- Creatinine, eGFR and urine albumin twice a year once stable; calcium, phosphate and PTH every six to twelve months; hemoglobin yearly; no statin now at 39 without diabetes or heart disease; no treatment for the uric acid without gout. [S]
- Pneumococcal, influenza, hepatitis B and COVID-19 vaccines. [S]
- Discussed with Dr. Whitcombe-Ibe, who saw him the same day. Mr. London asked plainly whether his kidneys would fail. He was told that his kidneys have lost about half their filtering, that the five-year risk of needing dialysis is about one in twenty, and that stopping alcohol and naproxen, controlling blood pressure and the two kidney-protecting medicines can slow or halt the decline. He chose naltrexone and agreed to wait for dapagliflozin. [S]
- Follow-up: Dr. Whitcombe-Ibe continues care at six, ten and twelve weeks; nephrology review in three months, or sooner for potassium above 5.5 mmol/L, a creatinine rise of more than 30 percent, blood in the urine, or rising albumin. [S]